Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Case report

Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report)

Authors: Martin Pencak, Jan Krasny, Miroslav Veith, Magdalena Vokrojova

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

To present a coincidence of macular telangiectasia type 2 and solitary retinal astrocytic hamartoma in one patient.

Case presentation

A 50-year-old woman was examined in the Department of Ophthalmology of University hospital Kralovske Vinohrady for complaints of metamorphopsia in her left eye. Her uncorrected visual acuity (VA) was 4/4 on Early Treatment Diabetic Retinopathy Study charts (ETDRS), on the retina of her left eye white, prominent, partially calcified tumour 1 disc diameter in diameter, 1,5 disc diameter from the foveola was detected on the retina. In the macular region of both eyes, parafoveal greying with crystalline deposits and changes in retinal vasculature were visible. We performed following examinations: fluorescein angiography (FA), B-scan ultrasound, spectral domain optical coherence tomography (SD-OCT) including photo documentation. FA showed partial hyperfluorescence of mulberry-like surface of the tumour typical for retinal astrocytic hamartoma. Parafoveally in both eyes, leakage from parafoveal telangiectasia was apparent. SD-OCT showed cystoid space in the macular region of both eyes as well as changes in inner and outer photoreceptor segment junction in left eye. SD-OCT of the tumour showed proliferation in retinal nerve fibre layer with normal structure of underlying retinal layers and choroid. Ultrasound examination of the tumour detected solid, highly echogenic prominent tumour with high reflectivity and acoustic shadow.

Conclusion

A coincidence of two relatively rare clinical units, macular telangiectasia type 2 and solitary astrocytic hamartoma was detected as a unique and rare observation.
Literature
1.
2.
Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993;100:1536–46.CrossRefPubMed
3.
Kiratli H, Bilgiç S. Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosis. Am J Ophthalmol. 2002;133:715–6.CrossRefPubMed
4.
Moschos MM, Chamot L, Schalenbourg A, et al. Spontaneous regression of an isolated retinal astrocytic hamartoma. Retina. 2005;25:81–2.CrossRefPubMed
5.
Gunduz K, Eagle Jr RC, Shields CL, et al. Invasive giant cell astrocytoma of the retina in a patient with tuberous sclerosis. Ophthalmology. 1999;106:639–42.CrossRefPubMed
6.
Shields CL, Shields JA, Eagle Jr RC, et al. Progressive enlargement of acquired retinal astrocytoma in two cases. Ophthalmology. 2004;111:363–8.CrossRefPubMed
7.
Shields JA, Eagle Jr RC, Shields CL, et al. Aggressive retinal astrocytomas in 4 patients with tuberous sclerosis complex. Arch Ophthalmol. 2005;123:856–63.CrossRefPubMed
8.
Shields JA, Eagle Jr RC, Shields CL, et al. Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex. Trans Am Ophthalmol Soc. 2004;102:139–47.PubMedPubMedCentral
9.
Mennel S, Meyer CH, Peter S, et al. Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand. 2007;85:127–32.CrossRefPubMed
10.
Tuncer S, Cebeci Z. Dramatic regression of presumed acquired retinal astrocytoma with photodynamic therapy. Middle East Afr J Ophthalmol. 2014;21:283–6.CrossRefPubMedPubMedCentral
11.
Boguszakova J. Oko a celkova onemocneni. In: Kuchynka et al., editors. Ocni lekarstvi. Praha: Grada; 2007. p. 727–47.
12.
Gerinec A. Detska oftalmologia. Osveta: Martin; 2005. p. 517–21.
13.
Svacinova J, Vlkova E, Kumstat Z. Syndrom Bourneville – Pringle. Cs Oftal. 1984;40:202–6.
14.
Streicher J, Spirkova J, Madaj R. Hamartomas of the optic disc and adjacent retina. Cesk Oftalmol. 1992;48:2–9.PubMed
15.
Mennel S, Meyer CH, Eggarter F, et al. Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis. Ophthalmologica. 2005;219:350–6.CrossRefPubMed
16.
Shields CL, Benevides R, Materin MA, et al. Optical coherence tomography of retinal astrocytic hamartoma in 15 cases. Ophthalmology. 2006;113:1553–7.CrossRefPubMed
17.
Shields JA, Shields CL, Ehya H, et al. Atypical retinal astrocytic hamartoma diagnosed by fine-needle biopsy. Ophthalmology. 1996;103:949–52.CrossRefPubMed
18.
Shields JA, Bianciotto CG, Kivela T, et al. Presumed Solitary Circumscribed Retinal Astrocytic Proliferation: The 2010 Jonathan W. Wirtschafter Lecture. Arch Ophthalmol. 2011;129:1189–94.CrossRefPubMed
19.
Yannuzzi LA, Bardal AM, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124:450–60.CrossRefPubMed
20.
Powner MB, Gillies MC, Tretiach M, et al. Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117:2407–16.CrossRefPubMedPubMedCentral
21.
Charbel Issa P, van der Veen RLP, Stifjs A, et al. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res. 2009;89:25–31.CrossRefPubMed
22.
Charbel Issa P, Scholl HP, Gaudric A, et al. Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye. 2009;23:435–41.CrossRefPubMed
23.
Aung KZ, Wickremasinghe SS, Makeyeva G, et al. The prevalence estimates of macular telangiectasia Type 2: the Melbourne Collaborative Cohort Study. Retina. 2010;30:473–8.CrossRefPubMed
24.
25.
Sallo FB, Leung I, Mathenge W, et al. The prevalence of type 2 idiopathic macular telangiectasia in two African populations. Ophthalmic Epidemiol. 2012;19:185–9.CrossRefPubMed
26.
27.
Parmalee NL, Schubert C, Figueroa M, et al. Identification of a potential susceptibility locus for macular telangiectasia type 2. PLoS One. 2012;7, e24268.CrossRefPubMedPubMedCentral
28.
Lowe MA, Akduman L, Olk RJ. Laser photocoagulation and glucose metabolism in idiopathic juxtafoveolar retinal telangiectasis. Ophthalmic Surg Lasers. 1998;29:126–39.PubMed
29.
Martinez JA. Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis. Arch Ophthalmol. 2003;121:1658–9.CrossRefPubMed
30.
Wu L, Evans T, Arevalo JF, et al. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia. Retina. 2008;28:314–9.CrossRefPubMed
31.
De Lahitte GD, Cohen SY, Gaudric A. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization. Am J Ophthalmol. 2004;138:892–4.CrossRefPubMed
32.
Sigler EJ, Randolph JC, Calzada JI, et al. Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2012;251:1097–101.CrossRefPubMed
33.
Charbel Issa P, Finger RP, Holz FG, et al. Eighteen-month followup of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol. 2008;92:941–5.CrossRefPubMed
34.
Charbel Issa P, Finger RP, Kruse K, et al. Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study. Am J Ophthalmol. 2011;151:876–86.CrossRefPubMed
35.
Matsumoto Y, Yuzawa M. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. Jpn J Ophthalmol. 2010;54:320–4.CrossRefPubMed
36.
Charbel Issa P, Holz FG, Scholl HPN. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology. 2007;114:1736–42.CrossRefPubMed
37.
Karagiannis D, Georgalas I, Ladas I, et al. A case of sub retinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis. Clin Interv Aging. 2009;4:63–5.PubMedPubMedCentral
38.
Konstantinidis L, Mantel I, Zografos L, et al. Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2009;247:1567–9.CrossRefPubMed
39.
Potter MJ, Szabo SM, Sarraf D, et al. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. Can J Ophthalmol. 2006;41:34–7.CrossRefPubMed
40.
Snyers B, Verougstraete C, Postelmans L, et al. Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol. 2004;137:812–9.CrossRefPubMed
41.
Charbel Issa P, Gillies MC, Chew EY, et al. Macular Telangiectasia Type 2. Prog Retin Eye Res. 2013;34:49–77.CrossRefPubMed
42.
Jost BF, Olk RJ. Atypical retinitis proliferans, retinal telangiectasis, and vitreous hemorrhage in a patient with tuberous sclerosis. Retina. 1986;6:53–6.CrossRefPubMed
Metadata
Title
Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report)
Authors
Martin Pencak
Jan Krasny
Miroslav Veith
Magdalena Vokrojova
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0377-z

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue

Research article

Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study

Research article

Choroidal thickness in obese women

Research article

Surgical outcomes of 23-gauge transconjunctival pars plana vitrectomy combined with lensectomy for glaucomatous eyes with extremely shallow anterior chamber and cataract

Research article

Dietary profile of patients with Stargardt’s disease and Retinitis Pigmentosa: is there a role for a nutritional approach?

Research article

Visualization of precut DSAEK and pre-stripped DMEK donor corneas by intraoperative optical coherence tomography using the RESCAN 700

Research article

Associations of vitamin D deficiency and vitamin D receptor (Cdx-2, Fok I, Bsm I and Taq I) polymorphisms with the risk of primary open-angle glaucoma